Conversely, although the lack of ALK expression on epithelial CTCs may raise concerns that these cells may not be related to the patient primary lung cancer, our data suggest that the emergence of epithelial ALK-negative CTCs may drive ALK-TKIs resistance mechanisms through the activation of ALK-independent pathways. The gene discussed is ALK; the disease is lung carcinoma.